The article discusses the U.S. Congressional Research Service report which provides an overview of Advanced Research Projects Agency for Health (ARPA-H) as proposed by the President Joe Biden Administration. It discusses selected policy issues still under debate as Congress considers legislation that would explicitly authorize ARPA-H.
The policy is expected to help the medical devices sector grow from the present $11 billion to $50 billion in the next five years [ABSTRACT FROM AUTHOR]
Kehres, Katherine M., Sheikh, Hassan Z., and Kirchhoff, Suzanne M.
Subjects
INSULIN, HEALTH insurance, MEDICARE Part D, DRUG prices, PHARMACEUTICAL policy, HEALTH policy
Abstract
The article provides an overview of insulin coverage in private health insurance plans and Medicare Part D in the U.S.. It discusses the cost of insulin, the types of insulin available, impact of high insulin costs on patients, potential policy solutions to address these costs, and recent legislative and regulatory actions aimed at improving insulin access and affordability including potential avenues for future policy action.
MEDICAID, HEALTH insurance, HEALTH policy, BENEFICIARIES, GROUP homes
Abstract
The article focuses on Long-term services and supports (LTSS) refer to a broad range of health and healthrelated services and supports needed by individuals who lack the capacity for self-care due to a physical, cognitive, or mental disability or condition. It mentions Medicaid institutional services to eligible beneficiaries, while the majority of Medicaid home and community based services (HCBS) are optional for states.
Published
2022
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.